Vito Spataro

1.3k total citations
26 papers, 1.0k citations indexed

About

Vito Spataro is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Vito Spataro has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Vito Spataro's work include Ubiquitin and proteasome pathways (5 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (4 papers). Vito Spataro is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (4 papers). Vito Spataro collaborates with scholars based in Switzerland, United Kingdom and United States. Vito Spataro's co-authors include Chris J. Norbury, Adrian L. Harris, Michele Genoni, Roberto Malacrida, Aldo P. Maggioni, A. W. Palmer, Tiziano Moccetti, Sarah Parish, Rory Collins and S. Pampallona and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Vito Spataro

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vito Spataro Switzerland 13 482 370 215 208 156 26 1.0k
Andreas Marinelli Netherlands 21 1.1k 2.2× 123 0.3× 914 4.3× 73 0.4× 279 1.8× 47 1.5k
Deepak Hariharan United Kingdom 11 381 0.8× 221 0.6× 410 1.9× 113 0.5× 190 1.2× 21 869
V.J. Harvey New Zealand 11 319 0.7× 226 0.6× 127 0.6× 62 0.3× 176 1.1× 24 678
Thomas J. Semrad United States 15 395 0.8× 257 0.7× 122 0.6× 56 0.3× 237 1.5× 51 890
Ketki Tendulkar United States 13 345 0.7× 167 0.5× 47 0.2× 45 0.2× 265 1.7× 22 645
Marija Bojić Austria 10 364 0.8× 283 0.8× 83 0.4× 353 1.7× 350 2.2× 39 948
B.K. Mohanti India 15 252 0.5× 211 0.6× 305 1.4× 49 0.2× 320 2.1× 58 994
Ali Manouchehri United States 7 978 2.0× 197 0.5× 81 0.4× 415 2.0× 287 1.8× 13 1.5k
Marilyn Mulay United States 11 365 0.8× 243 0.7× 71 0.3× 66 0.3× 250 1.6× 17 644
J. Wendall Goodwin United States 16 522 1.1× 186 0.5× 164 0.8× 115 0.6× 334 2.1× 34 1.0k

Countries citing papers authored by Vito Spataro

Since Specialization
Citations

This map shows the geographic impact of Vito Spataro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Spataro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Spataro more than expected).

Fields of papers citing papers by Vito Spataro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Spataro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Spataro. The network helps show where Vito Spataro may publish in the future.

Co-authorship network of co-authors of Vito Spataro

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Spataro. A scholar is included among the top collaborators of Vito Spataro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Spataro. Vito Spataro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spataro, Vito & Antoine Buetti‐Dinh. (2022). POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells. British Journal of Cancer. 127(5). 788–799. 19 indexed citations
2.
Peters, Solange, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, et al.. (2018). Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program. Journal of Thoracic Oncology. 13(12). 1897–1905. 66 indexed citations
3.
Peters, Solange, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, et al.. (2017). Activity of afatinib in heavily pretreated patients (pts) with HER2 mutation-positive (HER2m+) advanced non-small cell lung cancer (NSCLC): findings from a global named patient use (NPU) program. Annals of Oncology. 28. v484–v485. 2 indexed citations
4.
Balmelli, Cathrin, Michael Mark, Christian Spirig, et al.. (2014). Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations. memo - Magazine of European Medical Oncology. 7(3). 181–186.
5.
Spataro, Vito. (2010). Nilotinib in a Patient With Postnecrotic Liver Cirrhosis Related to Imatinib. Journal of Clinical Oncology. 29(3). e50–e52. 14 indexed citations
6.
Ravaioli, Alessandra, Franco Monti, Meredith M. Regan, et al.. (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology. 19(4). 660–668. 19 indexed citations
7.
8.
Spataro, Vito, et al.. (2003). The essential 26S proteasome subunit Rpn11 confers multidrug resistance to mammalian cells.. PubMed. 22(6C). 3905–9. 21 indexed citations
9.
Carobbio, Stefania, Claudio Realini, Chris J. Norbury, et al.. (2001). Sequence of Crm1/exportin 1 mutant alleles reveals critical sites associated with multidrug resistance. Current Genetics. 39(1). 2–9. 3 indexed citations
10.
Spataro, Vito, et al.. (2000). Acute Myeloid Leukemia in the Elderly: Results of an Individualized Approach in Two Centres. Leukemia & lymphoma. 39(5-6). 521–530. 10 indexed citations
11.
Allal, Abdelkarim S., Sabine Bieri, Vito Spataro, et al.. (2000). Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes. British Journal of Cancer. 82(6). 1131–1137. 119 indexed citations
12.
Spataro, Vito, et al.. (2000). ADENOCARCINOMA OF THE RETE TESTIS. The Journal of Urology. 164(4). 1307–1308. 11 indexed citations
13.
Malacrida, Roberto, Michele Genoni, Aldo P. Maggioni, et al.. (1998). A Comparison of the Early Outcome of Acute Myocardial Infarction in Women and Men. New England Journal of Medicine. 338(1). 8–14. 226 indexed citations
14.
Spataro, Vito. (1998). Recent advances in the molecular genetics of cancer. Annals of Oncology. 9(1). 23–29. 8 indexed citations
15.
Spataro, Vito, Chris J. Norbury, & Adrian L. Harris. (1998). The ubiquitin-proteasome pathway in cancer. British Journal of Cancer. 77(3). 448–455. 177 indexed citations
16.
Leyvraz, Serge, Vito Spataro, J. Bauer, et al.. (1997). Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.. Journal of Clinical Oncology. 15(7). 2589–2595. 130 indexed citations
17.
Spataro, Vito, Takashi Toda, Michael Seeger, et al.. (1997). Resistance to Diverse Drugs and Ultraviolet Light Conferred by Overexpression of a Novel Human 26 S Proteasome Subunit. Journal of Biological Chemistry. 272(48). 30470–30475. 71 indexed citations
18.
Spataro, Vito, E Pedrinis, & Wolfram Müller. (1994). Descriptive epidemiology of early and advanced gastric cancer in Ticino, Switzerland, with special emphasis on time trends. Annals of Oncology. 5(10). 954–956. 4 indexed citations
19.
Spataro, Vito & Claudio Marone. (1993). Rhabdomyolysis Associated with Bacteremia Due to Streptococcus pneumoniae: Case Report and Review. Clinical Infectious Diseases. 17(6). 1063–1064. 19 indexed citations
20.
Spataro, Vito, K. Price, Aron Goldhirsch, et al.. (1992). Sequential estrogen receptor determinations from primary breast cancer and at relapse: Prognostic and therapeutic relevance. Annals of Oncology. 3(9). 733–740. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Marinelli Breakdown of academic impact, for papers by Deepak Hariharan Breakdown of academic impact, for papers by V.J. Harvey Breakdown of academic impact, for papers by Thomas J. Semrad Breakdown of academic impact, for papers by Ketki Tendulkar Breakdown of academic impact, for papers by Marija Bojić Breakdown of academic impact, for papers by B.K. Mohanti Breakdown of academic impact, for papers by Ali Manouchehri Breakdown of academic impact, for papers by Marilyn Mulay Breakdown of academic impact, for papers by J. Wendall Goodwin
Rankless by CCL
2026